Caspofungin Acetate Injection
Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
Open FDA's page for this record- Discontinued date
- 06/30/2026
- Update type
- New
- Initial posting date
- 06/30/2026
- Package NDC
- 0781-3421-94
- Generic name
- Caspofungin Acetate Injection
- Contact info
- Sandoz: 800-525-8747
- Related info
- Marketed by Sandoz, Inc.; Discontinuation of the manufacture of the drug
- Update date
- 06/30/2026
- Dosage form
- Injection
- Presentation
- Caspofungin Acetate, Injection, 5 mg/1 mL (NDC 0781-3421-94)
- Company name
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
- Status
- To Be Discontinued
- Therapeutic category
- Anti-Infective
- Harmonized identifiers (openFDA)
- Application number
- ANDA200833
- Brand name
- CASPOFUNGIN ACETATE
- Generic name
- CASPOFUNGIN ACETATE
- Manufacturer name
- Sandoz Inc
- Product NDC
- 0781-3421, 0781-3423
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- CASPOFUNGIN ACETATE
- RxCUI
- 828539, 828755
- SPL ID
- d70d52c0-6601-f632-e053-2995a90a9291
- SPL set ID
- 722facc6-d4ea-4975-b83e-3ae63df69ed2
- Package NDC
- 0781-3421-01, 0781-3421-94, 0781-3423-01, 0781-3423-94
- UNII
- VUW370O5QE
